While acknowledging the strengths of the study, such as participant criteria, low drop-out rates and high adherence, the researchers also acknowledged limitations, including the relatively short intervention duration and the absence of a third intervention group receiving synbiotics alongside a placebo
Researchers investigating incretin-based compounds use Retatrutide as a reference molecule when comparing receptor selectivity and downstream signaling effects across the GLP-1/GIP/glucagon receptor family
This is not intended to suggest compounded medications are inferior or unsafe when obtained through legitimate channels
TREM2 protects from atherosclerosis by limiting necrotic core formation
Work with prescribers to consider discontinuation of overlapping medications, such as Sulfonylureas, Meglitinides, SGLT2 inhibitors, basal or prandial insulin and DPP-4 inhibitors